Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 9118.006 | 1.0030 | 1.0053 | 1.1089 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.0011 | uM | 9118.006 | 0.7945 | 0.6252 | 1.1089 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00548 | uM | 9118.006 | 1.0155 | 1.0280 | 1.1089 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.137 | uM | 9118.006 | 0.9389 | 0.8894 | 1.1089 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.685 | uM | 9118.006 | 0.9197 | 0.8545 | 1.1089 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7787.018 | 1.1731 | 2.0469 | 0.3791 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 7787.018 | 0.7954 | 0.0935 | 0.3791 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.000219 | uM | 7787.018 | 0.9439 | 0.7176 | 0.3791 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.0011 | uM | 7787.018 | 0.9365 | 0.6821 | 0.3791 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.137 | uM | 7787.018 | 0.8892 | 0.4671 | 0.3791 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.685 | uM | 7787.018 | 0.8887 | 0.4652 | 0.3791 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 9047.026 | 1.0116 | 1.0391 | 0.5972 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.0000438 | uM | 9047.026 | 0.8904 | 0.6465 | 0.5972 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.0274 | uM | 9047.026 | 0.6827 | 0.0555 | 0.5972 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 0.137 | uM | 9047.026 | 0.6391 | -0.0550 | 0.5972 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 9095.026 | 1.2784 | 1.5465 | 1.0168 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 9095.026 | 1.1888 | 1.3708 | 1.0168 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 0.0011 | uM | 9095.026 | 1.2242 | 1.4402 | 1.0168 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 0.00548 | uM | 9095.026 | 0.9080 | 0.8188 | 1.0168 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 0.137 | uM | 9095.026 | 0.6716 | 0.3521 | 1.0168 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 0.685 | uM | 9095.026 | 0.5548 | 0.1205 | 1.0168 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.0011 | uM | 7791.018 | 1.0204 | 1.0478 | 0.8558 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00548 | uM | 7791.018 | 1.0359 | 1.0840 | 0.8558 | |
AU565 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 0.0011 | uM | 7793.018 | 1.0003 | 1.0005 | 1.3186 | |
AU565 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 0.000219 | uM | 7793.018 | 1.0004 | 1.0007 | 1.3186 |